Related Experiment Video
Updated: May 20, 2026
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Quantitative and specific molecular imaging of cancer with labeled engineered monoclonal antibody fragments
Lauren T Rosenblum1, Peter L Choyke, Hisataka Kobayashi
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, NIH, Building 10, Room B3B69, 10 Center Dr., Bethesda, MD 20892-1088, USA.
Abstract:
The high target specificity of antibodies and related constructs makes them excellent scaffolds for molecular-imaging probes. Quantitative data on biodistribution and pharmacokinetics can be acquired by radiolabeling these agents. Such studies demonstrate prolonged circulation times and resulting nonspecific accumulation with high background signal using antibody-based agents. Antibody fragments demonstrate more rapid clearance, but lower tumor uptake. Optical labeling of antibodies provides a basis for developing activatable probes that can image antigens with very high specificity, potentially allowing for the simultaneous visualization of multiple targets. While radioimmunoimaging provides valuable whole-body, quantitative information, activatable optical antibody-based agents could generate real-time diagnostic and prognostic information about near-surface lesions at high-spatial and temporal resolution without requiring ionizing radiation.
Insights
Antibody-based molecular imaging probes offer high specificity for disease targets. Activatable optical probes show promise for real-time, high-resolution imaging without ionizing radiation.
Area of Science:
- Biomedical imaging
- Molecular biology
- Radiochemistry
Background:
- Antibodies and related constructs are valuable scaffolds for molecular imaging due to their high target specificity.
- Radiolabeling these agents allows for quantitative biodistribution and pharmacokinetic studies.
- Current antibody-based agents can exhibit prolonged circulation times, leading to nonspecific accumulation and high background signals.
- Antibody fragments offer faster clearance but reduced tumor uptake.
Purpose of the Study:
- To explore the potential of antibody-based agents for molecular imaging.
- To compare the characteristics of radiolabeled antibodies and antibody fragments.
- To investigate the development of activatable optical antibody-based probes for enhanced specificity and real-time imaging.
Main Methods:
- Utilizing antibodies and antibody fragments as scaffolds for molecular imaging probes.
- Employing radiolabeling techniques for quantitative biodistribution and pharmacokinetic analysis.
- Developing optical labeling strategies for antibody-based probes.
- Investigating activatable probe designs for enhanced specificity and signal generation.
Main Results:
- Antibody-based agents show high target specificity but can have prolonged circulation and high background signals.
- Antibody fragments clear faster but have lower tumor uptake compared to full antibodies.
- Optical labeling enables the development of activatable probes with high specificity for antigen imaging.
- Activatable optical probes offer potential for simultaneous visualization of multiple targets.
Conclusions:
- Antibody-based agents are promising for molecular imaging, with distinct advantages and disadvantages for full antibodies versus fragments.
- Activatable optical antibody-based agents represent a significant advancement, enabling high-specificity antigen imaging.
- These optical probes could provide real-time diagnostic and prognostic information for near-surface lesions with high spatial and temporal resolution.
- The development of activatable optical probes offers an alternative to radioimmunoimaging, avoiding ionizing radiation.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019